Intersecting Pandemics: Adrian Thomas of J&J on Tuberculosis (TB) & Covid-19

32:22
 
Share
 

Manage episode 294418795 series 2936678
By Center for Strategic and International Studies, Center for Strategic, and International Studies. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

To mark World TB Day, Katherine E. Bliss and J. Stephen Morrison speak with Adrian Thomas, TB expert and leader of global strategy at Johnson & Johnson Global Health. Every year, TB kills an estimated 1.4 million people and infects another 10 million people, with about 400,000 of those cases resistant to two or more drugs. Covid-19 has disrupted health systems and displaced funding and frontline staff away from TB, which models estimate will cause an additional million cases per year over the next five years. In this episode, we talk to Adrian about the grave impact the pandemic is having on global TB efforts, how to build local health security capacities that control TB and respond to future outbreaks, how international scientific partnerships speed up R&D and create platforms with broad applications, and the recent emergency use authorization by the FDA of J&J’s Covid-19 vaccine.

Adrian Thomas is Vice President for Strategy and External Affairs at Johnson & Johnson Global Health. The views expressed in the podcast are personal and not those of his employer.

16 episodes